skip to main content
Deft Research Logo

Blog

Is the Current C-SNP Growth Sustainable?

By Petra Brock, Senior Research Manager The Medicare Advantage (MA) market has seen massive membership growth, now accounting for more than half—51%—of all eligible Medicare beneficiaries.1 And although plans are projecting a decline in MA membership in 2026 of around 900,000 members, the Centers for Medicare & Medicaid Services (CMS)...
Read More

Subscribe Now and Save on Our 2026 Market Research Reports

  When it comes to unlocking unbeatable discounts on Deft Research’s cutting-edge insights, being an early adopter is the key to success. Pre-order our 2026 series of Medicare and Commercial Market syndicated reports by December 31, 2025, and enjoy significant discounts. Plus, you can receive additional discounts when you order...
Read More

Deft Research Becomes HITRUST Certified for Better Data Protection

Enhancing Data Security With HITRUST Certification At Deft Research, we understand that becoming the leading market research firm in health insurance requires a serious commitment to cybersecurity risk management. We support the strategic decision-making of many of the industry’s biggest players, making data privacy and security critical not only to...
Read More

The Place for Primary Research in a World Drowning in AI-Generated Data

Tom McGoldrick, VP of Research – Discover the blind spots inherent in AI-generated information and why direct customer research (surveys, interviews, and focus groups) are essential to predict future needs and stay ahead of the market. Currently, we are inundated with a wealth of unstructured data flowing in from social...
Read More

Prior Authorizations Coming to Traditional Medicare: A Conversion Opportunity for Medicare Advantage?

Emily Dykstra, Research Manager -    During plan year 2020, CMS established prior authorizations in Medicare Parts A and B for five very specific outpatient department (OPD) services and since has added only three to the list for a total of eight services.1 However, in January 2026, CMS will add...
Read More

Quantifying the IRA’s Impact: A 2023 to 2025 Drug Cost Comparison

Arielle Elliott, Research Manager -  The Medicare prescription drug market has undergone significant changes over the last three years, and likely much more change is still to come. With the passage of the Inflation Reduction Act in late 2022, particularly the establishment of the drug price negotiation program for 10...
Read More
Next >

Let's Chat

To purchase a study, discuss custom research options, or simply learn more, please share your contact info and a member of our staff will reach out.

By clicking the submit button, I expressly consent by electronic signature to receive communications via automatic telephone dialing system or by artificial/prerecorded message, email or by text message from Deft Research at the telephone number above (even if my number is currently listed on any state, federal, local or corporate Do Not Call list) including my wireless number if provided, for the purpose of marketing insurance products and services. Carrier message and data rates may apply. I understand that my consent is not required as a condition of purchasing any goods or services and that I may revoke my consent at any time. I also acknowledge that I have read and agree to the Privacy Policy and Terms & Conditions.

Not affiliated with or endorsed by the government or federal Medicare program.